Singapore to create animals with human DNA
By DPA,
DPA
| 01. 09. 2008
Scientists eager to splice human genes with animal cells are seeking a public feedback on the prospect of such controversial research, the Bioethics Advisory Committee (BAC) said on Wednesday.
A consultation paper on its website said the BAC considers human stem cell research to have considerable potential in the treatment of currently incurable diseases, such as diabetes, Alzheimer's disease and Parkinson's disease.
"While there have been significant advances in stem cell science and technology, research involving human-animal combinations is required for further progress," the BAC said.
Professor Lim Pin, BAC chairperson, said scientists overwhelmingly want to conduct research in a way that is ethical.
Those favouring such research maintain it could be vital to finding cures to many human diseases. Mice with human brain cells could be used as test beds for Parkinson's disease or Alzheimer's disease drugs, they said.
The city-state, with its ambitions to become a global bio-medical powerhouse, has the technology to create these "mixed animals" that can be created by infusing a human nucleus, the cell's nerve centre, with an animal egg or cell, Lim said...
Related Articles
By Jonathan Matthews, GMWatch | 12.11.2025
In our first article in this series, we investigated the dark PR tactics that have accompanied Colossal Bioscience’s de-extinction disinformation campaign, in which transgenic cloned grey wolves have been showcased to the world as resurrected dire wolves – a...
By Jessica Hamzelou, MIT Technology Review | 11.07.2025
This week, we heard that Tom Brady had his dog cloned. The former quarterback revealed that his Junie is actually a clone of Lua, a pit bull mix that died in 2023.
Brady’s announcement follows those of celebrities like Paris...
By Lauran Neergaard, AP News | 11.03.2025
WASHINGTON (AP) — The first clinical trial is getting underway to see if transplanting pig kidneys into people might really save lives.
United Therapeutics, a producer of gene-edited pig kidneys, announced Monday that the study’s initial transplant was performed successfully...
By Meagan Parrish, PharmaVoice | 10.10.2025
When CEO Ben Lamm steps into the spotlight, it’s usually to talk about his efforts bringing extinct animals back to life. Once a far-flung idea, Lamm and the company he heads, Colossal Biosciences, have proven they can pull it off...